Back to search

United States· US:63083-4449_bc143fb1-d232-4a0e-bc1f-6eab849fb0e4

H3N2 Influenza Nosode

A medicinal product containing influenza a virus a/south australia/55/2014 ivr-175 (h3n2) neuraminidase antigen (propiolactone inactivated), registered in United States by Professional Complementary Health Formulas.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedH3N2 Influenza NosodeATC—REGISTER NO.US:63083-4449_bc143fb…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
INFLUENZA A VIRUS A/SOUTH AUSTRALIA/55/2014 IVR-175 (H3N2) NEURAMINIDASE ANTIGEN (PROPIOLACTONE INACTIVATED)
Manufacturer
Professional Complementary Health Formulas
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    63083-4449-2
  • ndc11
    6308344492
    59 mL in 1 BOTTLE, DROPPER (63083-4449-2)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e9470cfb-6193-4283-a8ea-abacf4252188
GET /v1/drugs/e9470cfb-6193-4283-a8ea-abacf4252188?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "12",
  "substance": "INFLUENZA A VIRUS A/SOUTH AUSTRALIA/55/2014 IVR-175 (H3N2) NEURAMINIDASE ANTIGEN (PROPIOLACTONE INACTIVATED)",
  "productndc": "63083-4449",
  "dosage_form": "LIQUID",
  "dea_schedule": null,
  "strength_unit": "[hp_X]/59mL",
  "application_number": null,
  "marketing_category": "UNAPPROVED HOMEOPATHIC"
}

See everything about influenza a virus a/south australia/55/2014 ivr-175 (h3n2) neuraminidase antigen (propiolactone inactivated).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.